Literature DB >> 28352663

Retinol-binding protein 7 is an endothelium-specific PPARγ cofactor mediating an antioxidant response through adiponectin.

Chunyan Hu1, Henry L Keen1, Ko-Ting Lu1, Xuebo Liu1, Jing Wu1, Deborah R Davis1, Stella-Rita C Ibeawuchi1, Silke Vogel2, Frederick W Quelle1, Curt D Sigmund1,3.   

Abstract

Impaired PPARγ activity in endothelial cells causes oxidative stress and endothelial dysfunction which causes a predisposition to hypertension, but the identity of key PPARγ target genes that protect the endothelium remain unclear. Retinol-binding protein 7 (RBP7) is a PPARγ target gene that is essentially endothelium specific. Whereas RBP7-deficient mice exhibit normal endothelial function at baseline, they exhibit severe endothelial dysfunction in response to cardiovascular stressors, including high-fat diet and subpressor angiotensin II. Endothelial dysfunction was not due to differences in weight gain, impaired glucose homeostasis, or hepatosteatosis, but occurred through an oxidative stress-dependent mechanism which can be rescued by scavengers of superoxide. RNA sequencing revealed that RBP7 was required to mediate induction of a subset of PPARγ target genes by rosiglitazone in the endothelium including adiponectin. Adiponectin was selectively induced in the endothelium of control mice by high-fat diet and rosiglitazone, whereas RBP7 deficiency abolished this induction. Adiponectin inhibition caused endothelial dysfunction in control vessels, whereas adiponectin treatment of RBP7-deficient vessels improved endothelium-dependent relaxation and reduced oxidative stress. We conclude that RBP7 is required to mediate the protective effects of PPARγ in the endothelium through adiponectin, and RBP7 is an endothelium-specific PPARγ target and regulator of PPARγ activity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28352663      PMCID: PMC5358481          DOI: 10.1172/jci.insight.91738

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  54 in total

1.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes.

Authors:  Gemma Aragonès; Raimon Ferré; Iolanda Lázaro; Anna Cabré; Núria Plana; Jordi Merino; Mercedes Heras; Josefa Girona; Lluís Masana
Journal:  Atherosclerosis       Date:  2010-07-27       Impact factor: 5.162

3.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

4.  PPARgamma in endothelial cells influences high fat diet-induced hypertension.

Authors:  Christopher J Nicol; Masahiro Adachi; Taro E Akiyama; Frank J Gonzalez
Journal:  Am J Hypertens       Date:  2005-04       Impact factor: 2.689

5.  Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production.

Authors:  Jennifer M Kleinhenz; Dean J Kleinhenz; Shaojin You; Jeffrey D Ritzenthaler; Jason M Hansen; David R Archer; Roy L Sutliff; C Michael Hart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

6.  Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.

Authors:  Andreas M Beyer; Willem J de Lange; Carmen M Halabi; Mary L Modrick; Henry L Keen; Frank M Faraci; Curt D Sigmund
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

7.  PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice.

Authors:  Takeshi Kanda; Jonathan D Brown; Gabriela Orasanu; Silke Vogel; Frank J Gonzalez; Juliano Sartoretto; Thomas Michel; Jorge Plutzky
Journal:  J Clin Invest       Date:  2008-12-08       Impact factor: 14.808

8.  Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction.

Authors:  Chunyan Hu; Ko-Ting Lu; Masashi Mukohda; Deborah R Davis; Frank M Faraci; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2015-11-03       Impact factor: 3.107

9.  Muscle-specific Pparg deletion causes insulin resistance.

Authors:  Andrea L Hevener; Weimin He; Yaacov Barak; Jamie Le; Gautam Bandyopadhyay; Peter Olson; Jason Wilkes; Ronald M Evans; Jerrold Olefsky
Journal:  Nat Med       Date:  2003-11-16       Impact factor: 53.440

10.  Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells.

Authors:  Gemma Aragonès; Paula Saavedra; Mercedes Heras; Anna Cabré; Josefa Girona; Lluís Masana
Journal:  Cardiovasc Diabetol       Date:  2012-06-18       Impact factor: 9.951

View more
  15 in total

1.  Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging.

Authors:  T Michael De Silva; Ying Li; Dale A Kinzenbaw; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

2.  RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity.

Authors:  Masashi Mukohda; Shi Fang; Jing Wu; Larry N Agbor; Anand R Nair; Stella-Rita C Ibeawuchi; Chunyan Hu; Xuebo Liu; Ko-Ting Lu; Deng-Fu Guo; Deborah R Davis; Henry L Keen; Frederick W Quelle; Curt D Sigmund
Journal:  J Clin Invest       Date:  2019-03-21       Impact factor: 14.808

Review 3.  PPARγ and retinol binding protein 7 form a regulatory hub promoting antioxidant properties of the endothelium.

Authors:  Addison W Woll; Frederick W Quelle; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2017-09-15       Impact factor: 3.107

4.  Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.

Authors:  Larry N Agbor; Anand R Nair; Jing Wu; Ko-Ting Lu; Deborah R Davis; Henry L Keen; Frederick W Quelle; James A McCormick; Jeffrey D Singer; Curt D Sigmund
Journal:  JCI Insight       Date:  2019-06-11

Review 5.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

6.  Leptin Restores Endothelial Function via Endothelial PPARγ-Nox1-Mediated Mechanisms in a Mouse Model of Congenital Generalized Lipodystrophy.

Authors:  Thiago Bruder-Nascimento; Jessica L Faulkner; Stephen Haigh; Simone Kennard; Galina Antonova; Vijay S Patel; David J R Fulton; Weiqin Chen; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2019-10-28       Impact factor: 10.190

7.  Spatiotemporal analysis of human intestinal development at single-cell resolution.

Authors:  David Fawkner-Corbett; Agne Antanaviciute; Kaushal Parikh; Marta Jagielowicz; Ana Sousa Gerós; Tarun Gupta; Neil Ashley; Doran Khamis; Darren Fowler; Edward Morrissey; Chris Cunningham; Paul R V Johnson; Hashem Koohy; Alison Simmons
Journal:  Cell       Date:  2021-01-05       Impact factor: 41.582

8.  Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Protects From Angiotensin II-Induced Endothelial Dysfunction in Adult Offspring Born From Pregnancies Complicated by Hypertension.

Authors:  Anand R Nair; Sebastiao D Silva; Larry N Agbor; Jing Wu; Pablo Nakagawa; Masashi Mukohda; Ko-Ting Lu; Jeremy A Sandgren; Gary L Pierce; Mark K Santillan; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2019-05-20       Impact factor: 9.897

Review 9.  PPARγ and RhoBTB1 in hypertension.

Authors:  Shi Fang; Curt D Sigmund
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-03       Impact factor: 3.416

Review 10.  Role of the Peroxisome Proliferator Activated Receptors in Hypertension.

Authors:  Shi Fang; M Christine Livergood; Pablo Nakagawa; Jing Wu; Curt D Sigmund
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 23.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.